Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patients

BACKGROUND: The Japan Guidelines of Lung Cancer Therapy recommend epidermal growth factor receptor-tyrosine kinase inhibitors as a first-line therapy for advanced/recurrent non-small cell lung cancer patients with epidermal growth factor receptor mutation. Although survival periods in recent reports...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Akira, Yoshida, Kazushi, Morita, Satoshi, Imamura, Fumio, Seto, Takashi, Okamoto, Isamu, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki, Muto, Satoshi, Fukuoka, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874470/
https://www.ncbi.nlm.nih.gov/pubmed/26977054
http://dx.doi.org/10.1093/jjco/hyw014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874470/
https://www.ncbi.nlm.nih.gov/pubmed/26977054
http://dx.doi.org/10.1093/jjco/hyw014

Ejemplares similares